Tag: Quality Systems

Addressing Method Development Instability During Comparability Assessment for Smooth Tech Transfer In the pharmaceutical industry, method development stability is vital during comparability assessments, particularly when shifting from small-scale development to…

Understanding Underestimated Formulation Robustness in Early Development and Data Package Improvement Strategies Underestimating formulation robustness during the early stages of pharmaceutical development can lead to significant regulatory challenges, delays in…

Understanding the Impact of Excipient Variability During Pilot Scale: A CAPA Approach for Development Lifecycle Management In the pharmaceutical industry, managing excipient variability during the pilot scale is critical for…

Understanding Excipient Variability Impact During Scale-Up for Enhanced GMP Compliance In pharmaceutical manufacturing, the scale-up of processes can often unveil complexities, particularly related to excipient variability. This article will delve…

Understanding the Impact of Excipient Variability During Comparability Assessments In pharmaceutical manufacturing, excipients play a critical role in the formulation and final product quality of medicines. However, variability in these…

Managing Method Development Instability During Manufacturing Transition Method development instability during transfer to manufacturing can significantly disrupt operations, compromise product quality, and invite regulatory scrutiny. As pharmaceutical professionals working within…

Assessing Method Development Instability in Early Development and Its Impact on GMP Compliance In the complex landscape of pharmaceutical development, method development instability can pose significant risks to Good Manufacturing…

“`html Understanding the Impact of Excipient Variability During Pilot Scale: A Data-Driven Investigation Excipient variability during pilot scale can significantly affect the quality and consistency of pharmaceutical products. Such variability…

Identifying and Mitigating Scale-up Risks to Ensure GMP Compliance In the pharmaceutical industry, the transition from early development phases to full-scale manufacturing is critical yet fraught with potential risks. One…

Understanding Formulation Robustness Underestimation in Early Development and Its Regulatory Implications In the pharmaceutical industry, the robustness of a formulation during early development is crucial for ensuring product quality, consistency,…

Addressing Method Development Instability When Transitioning to Manufacturing In the competitive landscape of pharmaceutical development, the stability of analytical methods during the transfer to manufacturing can pose significant challenges. Inconsistent…

Addressing Readiness Gaps in Tech Transfer to Mitigate GMP Risks In the realm of pharmaceutical manufacturing, tech transfer during early development phases can present significant challenges. Often overlooked, these readiness…